Evidence map›Paper›PMID 24698976›Full record

ArticleHuman molecular genetics2014

Lesions from patients with sporadic cerebral cavernous malformations harbor somatic mutations in the CCM genes: evidence for a common biochemical pathway for CCM pathogenesis.

David A McDonald, Changbin Shi, Robert Shenkar, Carol J Gallione, Amy L Akers, Stephanie Li, Nicholas De Castro, Michel J Berg, David L Corcoran, Issam A Awad and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Human molecular genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed, 1 pooled it
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 1 synthesis or guideline pooled it, 139 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Endothelial Differentiation ofInternational journal of molecular sciences · 2023
    Article
  17. Article
  18. Review
  19. Article
  20. Review

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

David A McDonaldMolecular Genetics and Microbiology Department, Duke University Medical Center, Durham, NC 27710, USA.
Changbin ShiSection of Neurosurgery, Biological Sciences Division, University of Chicago, Chicago, IL 60637, USA.
Robert ShenkarSection of Neurosurgery, Biological Sciences Division, University of Chicago, Chicago, IL 60637, USA.
Carol J GallioneMolecular Genetics and Microbiology Department, Duke University Medical Center, Durham, NC 27710, USA.
Amy L AkersMolecular Genetics and Microbiology Department, Duke University Medical Center, Durham, NC 27710, USA Angioma Alliance, Norfolk, VA 23517, USA.
Stephanie LiMolecular Genetics and Microbiology Department, Duke University Medical Center, Durham, NC 27710, USA.
Nicholas De CastroMolecular Genetics and Microbiology Department, Duke University Medical Center, Durham, NC 27710, USA.
Michel J BergSchool of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY 14642, USA and.
David L CorcoranInstitute for Genome Sciences and Policy, Duke University, Durham, NC 27710, USA.
Issam A AwadSection of Neurosurgery, Biological Sciences Division, University of Chicago, Chicago, IL 60637, USA.
Douglas A MarchukMolecular Genetics and Microbiology Department, Duke University Medical Center, Durham, NC 27710, USA douglas.marchuk@duke.edu.
Duke University Hospital · USUniversity of Chicago · USDuke Medical Center · USDuke University · USUniversity of Rochester Medical Center · US

Funding

Re-Engineering Translational Research at the University of ChicagoUL1TR000430 · NCATS · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2012 to 2016
$20.2M
Genetics Training Grant-Year 26T32GM007754 · NIGMS · DUKE UNIVERSITY · PI HAASE, STEVEN B · 1985 to 2019
$8.3M
Rock Inhibition as Therapy for Cerebral Cavernous MalformationR01NS077957 · NINDS · UNIVERSITY OF CHICAGO · PI AWAD, ISSAM A, MARCHUK, DOUGLAS A. · 2012 to 2016
$2.3M
Genesis and Progression of Cerebral Cavernous MalformationsR01NS060748 · NINDS · DUKE UNIVERSITY · PI AWAD, ISSAM A, MARCHUK, DOUGLAS A. · 2009 to 2012
$2.0M
Studying Early-Stage Lesions in Mouse Models of Cerebral Cavernous MalformationsF31NS077702 · NINDS · DUKE UNIVERSITY · PI MCDONALD, DAVID A · 2011 to 2013
$50k
Investigation of the two-hit hypotesis for Cerebral Cavernous malformationsF31NS061468 · NINDS · DUKE UNIVERSITY · PI AKERS, AMY LEE · 2008 to 2008
$27k
NCATS NIH HHS UL1 TR000430NIGMS NIH HHS T32 GM007754NINDS NIH HHS F31 NS061468NINDS NIH HHS F31-NS061468NINDS NIH HHS F31 NS077702NINDS NIH HHS F31-NS077702NINDS NIH HHS R01 NS060748NINDS NIH HHS R01-NS060748NINDS NIH HHS R01 NS077957NINDS NIH HHS R01-NS077957
6 · The paper itself

Abstract

Cerebral cavernous malformations (CCMs) are vascular lesions affecting the central nervous system. CCM occurs either sporadically or in an inherited, autosomal dominant manner. Constitutional (germline) mutations in any of three genes, KRIT1, CCM2 and PDCD10, can cause the inherited form. Analysis of CCM lesions from inherited cases revealed biallelic somatic mutations, indicating that CCM follows a Knudsonian two-hit mutation mechanism. It is still unknown, however, if the sporadic cases of CCM also follow this genetic mechanism. We extracted DNA from 11 surgically excised lesions from sporadic CCM patients, and sequenced the three CCM genes in each specimen using a next-generation sequencing approach. Four sporadic CCM lesion samples (36%) were found to contain novel somatic mutations. Three of the lesions contained a single somatic mutation, and one lesion contained two biallelic somatic mutations. Herein, we also describe evidence of somatic mosaicism in a patient presenting with over 130 CCM lesions localized to one hemisphere of the brain. Finally, in a lesion regrowth sample, we found that the regrown CCM lesion contained the same somatic mutation as the original lesion. Together, these data bolster the idea that all forms of CCM have a genetic underpinning of the two-hit mutation mechanism in the known CCM genes. Recent studies have found aberrant Rho kinase activation in inherited CCM pathogenesis, and we present evidence that this pathway is activated in sporadic CCM patients. These results suggest that all CCM patients, including those with the more common sporadic form, are potentially amenable to the same therapy.

Indexed as

MutationApoptosis Regulatory ProteinsCarrier ProteinsCentral Nervous System NeoplasmsEndothelial CellsHemangioma, Cavernous, Central Nervous SystemHumansKRIT1 ProteinMembrane ProteinsMicrotubule-Associated ProteinsProto-Oncogene Proteinsrho-Associated KinasesApoptosis Regulatory ProteinsCarrier ProteinsCCM2 protein, humanKRIT1 ProteinKRIT1 protein, humanMembrane ProteinsMicrotubule-Associated ProteinsPDCD10 protein, humanProto-Oncogene Proteinsrho-Associated Kinases

Identifiers

PMID24698976
PMCPMC4103679
OpenAlexW2147385774

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.